ZENAS BIOPHARMA, INC.

Profile

Company Names

ZENAS BIOPHARMA, INC.
ZENAS BIOPHARMA (CAYMAN) LTD

Addresses

1000 WINTER ST, SUITE 1200, WALTHAM, MA 02451

Phone Numbers

857-271-2954

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

CAYMAN ISLANDS

Total Amount Raised:

$384,044,167.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-05-03 
$200,145,732.00 
$200,145,732.00 
$0.00 
Equity 
1
2022-11-02 
$183,898,435.00 
$183,898,435.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICIA 
 
ALLEN 
DIRECTOR
YUMANITY HOLDINGS, LLC   |  ZENAS BIOPHARMA, INC.
JAMES 
PATRICK 
BOYLAN 
DIRECTOR
ZENAS BIOPHARMA (CAYMAN) LTD   |  ZENAS BIOPHARMA, INC.
PATRICK 
GERALD 
ENRIGHT 
DIRECTOR
ZENAS BIOPHARMA (CAYMAN) LTD   |  ZENAS BIOPHARMA, INC.
JOSEPH 
 
FARMER 
EXECUTIVE OFFICER
XILIO THERAPEUTICS, INC.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  ZENAS BIOPHARMA, INC.
TANYA 
Z. 
FISCHER 
EXECUTIVE OFFICER
ZENAS BIOPHARMA, INC.
JENNIFER 
 
FOX 
EXECUTIVE OFFICER
TS EXECUTIVE ABSTRACT, LLC   |  TS INVESTORS, LLC   |  ZENAS BIOPHARMA, INC.
TOMAS 
 
KISELAK 
DIRECTOR
FAIRMOUNT HEALTHCARE FEEDER FUND LTD.   |  FAIRMOUNT HEALTHCARE FUND L.P.   |  QUELLIS BIOSCIENCES, INC.   |  VIRIDIAN, LLC   |  FAIRMOUNT HEALTHCARE FEEDER FUND II LTD.   |  FAIRMOUNT HEALTHCARE FUND II L.P.   |  VIRIDIAN THERAPEUTICS, INC.   |  MIRAGEN THERAPEUTICS, INC.   |  DIANTHUS THERAPEUTICS, INC.   |  INTERIUS BIOTHERAPEUTICS, INC.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  FAIRMOUNT HEALTHCARE CO-INVEST L.P.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE FEEDER FUND II L.P.   |  FAIRMOUNT HEALTHCARE CO-INVEST II L.P.   |  SPYRE THERAPEUTICS, INC.   |  ZENAS BIOPHARMA, INC.
HONGBO 
 
LU 
DIRECTOR
CROWN BIOSCIENCE, INC   |  AVEDRO INC   |  TP THERAPEUTICS, INC.   |  PERFUSE THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  RGENTA THERAPEUTICS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  BLOSSOMHILL THERAPEUTICS, INC.   |  ZENAS BIOPHARMA, INC.
LEON 
O. 
MOULDER, JR. 
DIRECTOR, EXECUTIVE OFFICER
TESARO, INC.   |  INTERIUS BIOTHERAPEUTICS, INC.   |  DIANTHUS THERAPEUTICS, INC.   |  NAVROGEN, INC.   |  PRAEVENTIX, INC.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  NAVROGEN INC.   |  ZENAS BIOPHARMA, INC.
HUA 
 
MU 
EXECUTIVE OFFICER, DIRECTOR
ZENAS BIOPHARMA (CAYMAN) LTD
JAKE 
 
NUNN 
DIRECTOR
HYPERION THERAPEUTICS INC   |  TV2 HOLDING CO   |  ACIEX THERAPEUTICS, INC.   |  DERMIRA, INC.   |  TRIVASCULAR TECHNOLOGIES, INC.   |  ADDEX THERAPEUTICS LTD.   |  ZENAS BIOPHARMA, INC.
JOHN 
JACOB 
ORLOFF 
DIRECTOR
ZENAS BIOPHARMA (CAYMAN) LTD   |  ZENAS BIOPHARMA, INC.
MARIETTA 
 
WU 
DIRECTOR
ZENAS BIOPHARMA (CAYMAN) LTD
TIM 
 
XIAO 
DIRECTOR
THERMALIN INC.   |  ZENAS BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-05-03 
2022-11-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#